Idera Pharmaceuticals reported $2.33M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Aceto ACET:US 5.21M 188K
Agenus AGEN:US $ 21.38M 4.73M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amgen AMGN:US $ 1.31B 79M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Cytrx CYTR:US 1.53M 354.61K
Dynavax Technologies DVAX:US $ 26.93M 5.85M
Eli Lilly And LLY:US $ 1.58B 107.8M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Idera Pharmaceuticals IDRA:US $ 2.33M 141K
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Pfizer PFE:US $ 2.73B 61M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
X T L Biopharmaceuticals XTLB:US 245K 40K